MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2025 International Congress

October 5-9, 2025. Honolulu, Hawaii.

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • Archimedes spiral based non-linear regression machine learning model for predicting tremor’s severity

    A. Rekik, S. Laatoui, M. Abid, R. Guizani, I. Rekik, S. Ben Amor (Sousse, Tunisia)

  • Are All Postural Reflexes Facilitated by Instability

    J. Colebatch, D. Hochstrasser, N. Todd, S. Govender (Sydney, Australia)

  • Are Hallucinations in Parkinson’s Driven by Over-Reliance on Prior Information?

    A. Holden, M. Macaskill, D. Myall, C. Le Heron, S. Lewis, T. Anderson, K-L. Horne (Christchurch, New Zealand)

  • Are There Differences in Non-Motor Outcomes of Parkinson’s Disease Treated with GPi vs. STN Deep Brain Stimulation?

    G. Rodriguez Garcia, G. Hey, A. Martinez Nunez, J. Hilliard, A. Ramirez-Zamora (Gainesville, USA)

  • Are we there yet? A Comprehensive Assessment of the Challenges in Standardizing MRgFUS Outcomes in Essential Tremor

    L. Knight, R. Martuscello, I. Pyle, A. Sanchez Fraga, C. Ferrer, K. Gant, A. Grinspan (Miami, USA)

  • Arginase2 – a potential mediator in the pathology of the stratum

    M. Nalepa, K. Synoradzki, A. Skweres, A. Owczarek, M. Gewartowska, M. Wegrzynowicz (Warsaw, Poland)

  • Artificial Intelligence for Education in Movement Disorders

    S. Garg, G. Amorelli (Ottawa, Canada)

  • Artificial Intelligence for Understanding Parkinson Disease State and Patient Stratification Using CSF Proteomics

    L. Abu Zohair, H. Zantout, M. Vallejo, M. Uddin (Edinburgh, United Kingdom)

  • Artificial Intelligence in the Early Detection of Parkinson’s Disease: Advances, Challenges, and Future Perspectives

    ME. Mellaci (SÃO PAULO, Brazil)

  • Artificial Intelligence Unveils Genetic Etiologies in Parkinson’s Disease: Cases Clustered by Clinical Features

    G. Di Rauso, A. Ghibellini, F. Pirone, G. Franco, F. Arienti, E. Frattini, I. Trezzi, F. Cavallieri, L. Bononi, M. Gabbrielli, F. Valzania, E. Monfrini, A. Di Fonzo (Reggio Emilia, Italy)

  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 181
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley